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Background and purpose   Two-stage revision remains the gold 
standard in the treatment of infected knee arthroplasty. Lately, 
good long-term results of direct exchange arthroplasty have been 
reported. The purpose of this literature review is to compare the 
clinical outcome achieved with one-stage revision and two-stage 
revision with different types of spacers.
Methods      A  thorough  systematic  review  of  literature  was 
undertaken  to  identify  reports  on  the  treatment  alternatives. 
Papers written in English or including an English abstract, pub-
lished from 1980 through 2005, and reporting either the success 
rate  in  eradication  of  infection  or  the  clinical  status  achieved 
were reviewed. 31 original articles describing the results of 154 
one-stage exchange arthoplasties and of 926 two-stage exchange 
arthoplasties were included. The depth of detail in the description 
of materials and methods varied markedly, making it impossible 
to perform a meta-analysis. Instead, a descriptive review of the 
results is presented. 
Results   With a follow-up of 12–122 months, the overall suc-
cess rate in eradication of infection was 73–100% after one-stage 
revisions  and  82–100%  after  two-stage  revisions.  Reinfection 
rates were the lowest in series where articulating cement spac-
ers were used, though the follow-up was relatively short. Studies 
using articulating spacers reported the highest average postoper-
ative ranges of motion. Otherwise, no correlations were observed 
between the clinical outcome and the length of follow-up, the type 
of revision, or the type of spacer. The clinical outcome (knee scores 
and range of motion) of the one-stage revisions was no different 
from that of the two-stage revisions.
Interpretation   Two-stage exchange is an effective treatment. 
Mobile spacers may further improve the range of motion. More 
experience in one-stage revision is required in order to define its 
role in the management of infected knee arthroplasties.   

Two-stage exchange arthroplasty has remained the gold stan-
dard  in  the  treatment  of  infected  total  knee  arthroplasties 
(TKAs) for over two decades (Leone and Hanssen 2006). The 
original concept (Insall et al. 1982, 1983) has been modified 
by several authors. Spacer block technique was first developed 
to avoid scarring of the joint during the interim period, and to 
work as a local antibiotic carrier (Borden and Gearen 1987, 
Cohen et al. 1988). Later, articulating spacers were introduced 
to enhance the patient’s functional status and to maintain the 
range of motion during the period between the two stages 
(Masri et al. 1994, Hofmann et al. 1995, Fehring et al. 2000) 
to improve the often poor knee score and patient satisfaction 
(Barrack et al. 2000b, Wang et al. 2004). Irrespective of the 
type of spacer used, satisfactory outcomes in terms of infec-
tion eradication have been reported.
Very little has been published on one-stage revision in the 
literature (Silva et al. 2002), but promising long-term results 
have been reported (Buechel et al. 2004). The studies that have 
been published suggest that direct exchange may have a role in 
the management of infected knee arthroplasties, but this role is 
not clear at present. It is also unclear whether the type of spacer 
used in two-stage revision affects the outcome. Thus, we per-
formed this systematic review to assess the effect of treatment 
approach on the outcome of infected knee arthroplasty.
Material and methods
In January 2006, we searched several international databases 
using  highly  sensitive  though  somewhat  unspecific  search 
strategies, which are described in detail in Appendix 1. The 
literature search strategies were created in co-operation with a 
librarian. The research plan was reviewed and approved by the 68  Acta Orthopaedica 2009; 80 (1): 67–77
Finnish Office for Health Technology Assessment (see http://
finohta.stakes.fi/).
Two of the present authors (EJ and IS) reviewed the search 
results independently and classified the references found in 
terms of whether they should be included on basis of the title 
of the paper (Table 1), whether they should be excluded, or 
whether this was unclear. Abstracts of unclear references were 
reviewed and papers were then classified as being included or 
excluded. In addition to original study reports, review articles 
and articles dealing with the treatment costs of infected knee 
replacements were reviewed. Reference lists from all reviewed 
articles were assessed to complete the literature search. The 
two reviewers’ lists of papers that should be included were 
compared to each other, and where there was any discrepancy, 
they were re-classified according to the consensus reached. 
The list of articles included was reviewed by an expert on the 
subject who did not belong to the study group and it was found 
to fulfill the inclusion criteria. 
Finally, 25 original studies published in English (Rosen-
berg et al. 1988, Booth and Lotke 1989, Henderson et al. 
1991, Göksan and Freeman 1992, Masri et al. 1994, White-
side 1994, Gusso et al. 1995, Goldman et al. 1996, McPher-
son et al. 1997, Hirakawa et al. 1998, Fehring et al. 2000, 
Haddad et al. 2000, Mont et al. 2000, Lonner et al. 2001, 
Emerson et al. 2002, Siebel et al. 2002, Jhao and Jiang 2003, 
Buechel et al. 2004, Durbhakula et al. 2004, Haleem et al. 
2004, Meek et al. 2004, Cuckler 2005, Hofmann et al. 2005, 
MacAvoy and Ries 2005, Pitto et al. 2005) and 6 studies pub-
lished in other languages (von Foerster et al. 1991, Gacon 
et al. 1997, Lu et al. 1997, Lecuire et al. 1999, Kirschner et 
al. 2000, Pietsch et al. 2003) between 1983 and 2005 were 
included. The materials of several studies (Insall et al. 1983, 
Wilde and Ruth 1988, Hofmann et al. 1995, 2005, Goldman 
et al. 1996, Hirakawa et al. 1998, Windsor et al. 2000, Meek 
et al. 2003, 2004) were identical. In such cases, the most 
recent report (Goldman et al. 1996, Hirakawa et al. 1998, 
Meek et al. 2004) was accepted for further analysis. In addi-
tion, reports by Booth and Lotke (1989) and Henderson and 
Booth (1991) presented partly overlapping data, but these 
studies were reviewed separately.
Data about materials, methods, and results of each original 
article included was extracted into a specific form indepen-
dently by EJ and IS. Each study was assessed using a checklist 
(Appendix 2). The checklist, based on previously published 
criteria for evaluation of the internal validity (van Tulder et al. 
1997) and generalizability (Malmivaara et al. 2006) of studies 
in systematic reviews, was customized for the context of this 
review. The quality score calculated was not used as an exclu-
sion criterion.
The materials extracted by EJ and IS were compared to each 
other and conflicting data were re-checked from the original 
papers and corrected after discussion.
The principal outcomes were (1) the rates of new and recur-
rent  infections  and  (2)  the  clinical  outcome—measured  as 
postoperative clinical knee score and range of motion—fol-
lowing  the  revision  arthroplasty.  Due  to  heterogeneity  and 
to the low calculated quality scores in the reports, the study 
materials were not pooled using meta-analytical techniques. 
Instead, several graphs were prepared for the principal out-
come variables in order to visualize any possible trend after 
sorting the materials by a potentially explanatory variable. A 
qualitative and descriptive summary of the results is also pre-
sented.
Results
The studies reported the results of 926 two-stage and 152 
one-stage arthroplasties (Table 2). The number of operations 
reported in any one study varied between 5 and 104, and the 
average length of follow-up ranged from 12 to 122 months. In 
total, 3,718 and 986 case-years of follow-up were reported for 
two-stage and one-stage revisions, respectively. 
Table 1. The inclusion criteria for original papers
The report concerns the results of management of infected knee arthroplasty only with one-stage or two-stage exchange arthroplasty.
The study can be classified into one of the following groups: 
–  randomized controlled trial
–  prospective study comparing two simultaneous treatment groups
–  prospective study with historical controls
–  prospective case series with no comparison group
–  retrospective study comparing two simultaneous treatment groups
–  retrospective study with historical control group
–  retrospective study with no control group
Study includes more than 5 cases treated.
The paper is written in English or it has an abstract in English.
One or more of the following outcome variables is reported:
–  number of all infections appearing after the treatment
–  number of reinfections
–  clinical status at follow-up, reported using Hospital for Special Surgery or Knee Society knee score
–  range of motion at follow-upActa Orthopaedica 2009; 80 (1): 67–77  69
Study methodology and quality
None of the studies included used a randomized or controlled 
trial  setting.  In  2  studies  of  two-stage  revisions,  historical 
comparison groups were used to analyze the effect of spacer 
type on treatment outcome (Fehring et al. 2000, Emerson et al. 
2002). 5 studies stated that the materials had been collected in 
a prospective manner (Whiteside 1994, Goldman et al. 1996, 
Mont et al. 2000, Siebel et al. 2002, Pitto et al. 2005). In a con-
siderable number of studies, either materials or the treatment 
intervention—or both—was incompletely described (Table 3). 
All the outcome variables of interest for this systematic review 
were reported in only 10 series. The total quality score ranged 
from 8 to 17 out of a maximum of 20 points. Quality score 
was not calculated for the 6 reports in languages other than 
English.
Treatment interventions
Table 2 gives a summary of materials and treatment approaches 
of the studies reviewed. Measured by the number of cases and 
the total case-years of follow-up, best experience has been 
reported with static polymethylmethacrylate (PMMA) spac-
ers (52 to 691 case-years of follow-up). Medium- to long-term 
Table 2. Original studies included: materials and outcome
Study    Materials    Outcome
  A  B  C  D  E  F  G  H  I
Rosenberg et al.   1988  26  1981–1986  65/31/4  67  2-stage, no spacer  29 (12–57)  100  78  NA
Booth and Lotke a  1989  25  1984–1988  NA  67  2-stage, PMMA block   25 (6–59)  96  82  100
Henderson and Booth a   1991  28   1984–1989   89/11/0   73   2-stage, PMMA block    27 (12–79)   97   86   90
von Foersteret et al. c  1991   104   1976–1985   61/29/10   NA  1-stage   76 (60–180)  73   NA   NA
Göksan and Freeman  1992   18   1979–1989   39/56/5   61   1-stage    60 (12–120)   94   NA   85
Masri et al.   1994   24   1987–1993   75/8/17   66   2-stage, PROSTALAC  26 (6–73)  96  80  86
Whiteside   1994   33   NA   85/15/0   NA  2-stage, PMMA block   24   97  NA  98
Gusso et al.    1995   5   NA   80/NA/NA   NA   2-stage, PMMA block  (4–18)   100   78   105 
Goldman et al.   1996   64   1977–1993   70/25/5   67   2-stage, no spacer b    90 (24–204)   97   78   94
Gacon et al. c   1997   29   1984–1994   97/3/0   70   2-stage, PMMA block    42   83   80   95
Lu et al. c   1997   8   NA   NA   NA   1-stage    20   100   NA   NA
McPherson et al.  1997   21   1993–1996   NA   64   2-stage, no spacer    17 (5–33)   95   77   99
Hirakawa et al.   1998   55   1980–1993   75/25/0   67   2-stage, PMMA block    NA   82   79   83
Lecuire et al. c   1999   12   1989–1998   NA   NA   2-stage, no spacer    12   100   NA   96
Fehring et al.   2000   25   1986–1995   NA   68   2-stage, PMMA block    36 (24–72)   88   83   98
     15   1996–1999   NA   NA   2-stage, artic. PMMA     27 (24–36)   93   84   105
Haddad et al.    2000  45   1987–1996   80/13/7   69   2-stage, PROSTALAC    48 (20–112)   98   72   95
Kirschner et al. c   2000   6   1996–1997   NA   62   2-stage, artic. PMMA     19 (13–21)   100   NA   NA
Mont et al.    2000   69   1989–1993   NA   66   2-stage, PMMA block    63 (36–114)   93   86   96
Lonner et al.    2001   53   1983–1997   NA   NA  2-stage, PMMA block   56 (24–144)   91   NA   NA
Emerson et al.    2002   26   1986–1994   NA   66   2-stage, PMMA block    90 (34–152)   92   NA   94
      22   1995–1999   NA   65   2-stage, RPS    46 (31–77)   100   NA   108
Siebel et al.   2002   10   NA   NA   66   2-stage, artic. PMMA    18 (6–26)   100   64   87
Jhao and Jiang   2003   7   1994–2001   86/14/0   68   2-stage, no spacer    42 (12–84)   100   86   91
Pietsch et al. c   2003   24   1999–2002   NA  d  2-stage, RPS    15 (5–33)   96   NA   NA
Haleem et al.   2004   96   1989–1994   77/15/8   69   2-stage, PMMA block    86 (30–158)   96   50   90
Buechel et al.   2004   22   1981–1993   95/5/0   71  1-stage    122 (17–235)   100   80   NA
Durbhakula et al.   2004   24   1998–2001  NA   72   2-stage, artic. PMMA    33 (28–51)  100   82   104
Meek et al.   2004   54   1997–1999   NA   NA   2-stage, PROSTALAC    41   96   76   87
Cuckler   2005   44   1994–2002   NA   68   2-stage, RPS    65 (24–120)   100   84   112
Hofmann et al.   2005   50   1989–2001  NA   67   2-stage, RPS    74 (24–150)   94   89   4–104
MacAvoy and Ries  2005   13   NA   NA   58   2-stage, B&S    28 (15–44)   100   NA   98
Pitto et al.   2005   21   2000–2003   NA   67   2-stage, artic. PMMA    24 (12–43)   100   81   94
OA: osteoarthritis; RA: rheumatoid arthritis; ROM: range of motion; NA: not available; PMMA: polymethylmethacrylate bone cement; PROSTA-
LAC: prosthesis of antibiotic-loaded cement; RPS: resterilized prosthesis spacer; B&S: ball-and-socket spacer; 
a partly overlapping data; 
b includes 7 knees with PMMA block, 
c non-English publications.
d range 42–78
A  No. of knees 
B  Year(s) of collection
C Diagnosis OA/RA/other, % 
D Average age at operation, years 
E  Revision type, spacer  
F  Length of follow-up, months (range) 
G Rate of eradication of infection, % 
H Average clinical knee score postoperatively 
I  ROM or flexion postoperatively, degrees70  Acta Orthopaedica 2009; 80 (1): 67–77
follow-up has also been reported for resterilized prosthesis 
spacers  (RPSs,  resterilized  removed  femoral  components 
with either a new or resterilized tibial polyethylene insert) and 
one-stage revision. The experience is shortest with articulat-
ing PMMA spacers (10–66 case-years) and with the ball-and-
socket spacer, used to manage knees with remarkable liga-
mentous laxity and bony defects (30 case-years). 
In all studies, patients were given intravenous antibiotics after 
the first-stage operation, usually for 4–6 weeks. The details 
of antibiotic treatment (average length, antibiotic selection, 
use of oral antibiotics) were often unavailable, however, and 
only half of the studies reported the exact length of the interim 
period between the two stages (range of averages, 43–175 
days). After reimplantation arthroplasty, a common protocol 
seems to have been to continue intravenous antibiotics until 
the results of operative bacterial cultures were ready. There 
appeared to be a correlation between publication year (rather 
than spacer type) and the duration of the interim period, with 
the most recent studies reporting shortest interim periods (data 
not shown). After one-stage revisions, antibiotics were given 
intravenously for periods ranging from 1–2 weeks (Göksan 
and Freeman 1992) to 4–6 weeks (Buechel et al. 2004).
There were no statistically significant differences in patient 
demographics (Table 2), types of detected pathogens (the pro-
portion of staphylococcal species was 48–85%), or the quality 
score of the studies (not shown) between the studies concern-
ing different spacer types or between the studies on two-stage 
or direct revision. The type of infection (acute vs. chronic) and 
the time from index arthroplasty to resection of the infected 
prosthesis were reported too seldom to enable comparison of 
the studies in these respects.
Eradication of infection
Success in infection management was analyzed in three ways. 
Firstly, the total number of infections appearing after treat-
ment was recorded, supplemented by the number of recurrent 
infections and of new infections (that is, postoperative infec-
tions caused by an organism other than the one detected upon 
treatment). After the index revision, deep knee infection was 
detected in 0–31% of cases. The treated infections recurred in 
0–18% of the cases. The new infection rate varied from 0 to 
31%.The length of follow-up did not appear to affect the rate 
of recurrent infections, but the reports with follow-up of < 4 
years had few new infections (Figure 1).
The lowest rates of recurrent infection were reported in stud-
ies where no spacer was used (0–5%) (Table 2). Also, resteril-
ized prosthesis spacers, articulating PMMA spacers, and one-
stage revision groups had low recurrence rates (0–6%, 0–7%, 
and 0–6%, respectively). No association was seen between 
type of spacer and the rate of new infections, although in the 
ball-and-socket spacer series with relatively young patients 
an exceptionally high number of new infections was reported 
(31%). The indication for primary arthroplasty (osteoarthritis 
or other), mean age, or the pathogen identified did not appear 
to affect the incidence of post-revision infection rates (data not 
shown). When the series were sorted by the year of publica-
tion, a decline in recurrent infection rate was seen in the most 
recent studies (Figure 2).
Clinical outcome
Knee Society knee score and Hospital for Special Surgery 
knee score were used to measure the clinical outcome in most 
studies. Even more frequently, postoperative range of motion 
or  maximal  flexion  was  reported  (Table  3).  Preoperative 
scores were reported in 9 studies only. Comparisons between 
different treatment approaches were made in two ways: firstly, 
the studies were grouped by treatment approach (one vs. two 
stages) and spacer ideology (no spacer, static spacer, articu-
lating spacer), and then different spacer types were analyzed 
separately.
The highest average postoperative ranges of motion or max-
imal flexion exceeding 100 degrees (104–112 degrees) were 
achieved with articulating spacers (Fehring et al. 2000, Emer-
son et al. 2002, Durbhakula et al. 2004, Cuckler 2005), but the 
small study by Gusso et al. (1995) also reported average flex-
ion of 105 degrees (Figure 3). Other studies reported values 
Table 3. Quality scores of the 25 studies published in English that 
were included. Values are number of studies
Quality measure  Measure   Measure 
     reported  not 
    reported
Materials  
  Average age  21  4
   Male-to-female ratio   23   2
   Primary diagnoses   13   12
   ASA or other risk classification   2   23
   Pathogens   23   2
   Preoperative clinical knee score   9   16
   Preoperative range of motion or flexion range   9   16
Intervention  
   Peroperative antibiotic treatment   19   6
   Type of spacer   22   1
   Mean time between the two stages   16   7
   Postoperative antibiotic treatment   9   16
   Rehabilitation   6   19
Results  
  No. of all new infections   25   0
  No. of reinfections/recurrent infections   24   1
   No. of other failures   11   14
   Postoperative clinical knee score   20   5
  Postoperative range of motion/flexion  23   2
     True  False
Methodology  
   Were both advantages and disadvantages of  
    the treatment described?   8   17
   Was the number of patients excluded less  
    than 20% of the number of patients included?   21   4
   Was the species of pathogen identified used 
    as an exclusion criterion?   3   22
   Was loss to follow-up less than 20%?   25   0Acta Orthopaedica 2009; 80 (1): 67–77  71
ranging from 80 to 100 degrees. Despite the type of spacer, 
there was considerable variance so no definitive conclusions 
can be drawn. Most studies reported an average clinical score 
of at least 80 out of 100. No obvious trend was seen when 
clinical outcome was compared to any of the various explana-
tory variables (length of follow-up, revision type, spacer type). 
There was no difference in outcome with one-stage revisions 
and two-stage revisions.
Data that can allow calculation of the change from preop-
erative to latest postoperative range of motion or clinical score 
were available in 9 studies. Except for 1 report (Hirakawa et 
al. 1998), considerable improvement was seen irrespective of 
the spacer type. The highest improvements in clinical scores 
were achieved with static PMMA spacers (Gusso et al. 1995, 
Haleem et al. 2004) or resterilized prosthesis spacers (Cuckler 
2005), while the change in range of motion was highest in 
series with articulating spacers (Haddad et al. 2000, Emerson 
et al. 2002, Pitto et al. 2005). Hirakawa et al. (1998) reported a 
Discussion
Despite the relatively high number of reports on the treatment 
of infected TKAs with exchange arthroplasty, there is a lack 
of prospective comparative trials. Most of the studies reviewed 
were retrospective case series and failed to describe materi-
als, surgical technique, or both in enough detail—thus making 
it difficult to compare the studies to each other. The studies 
published after the literature searches of our study (Hart and 
Jones 2006, Huang et al. 2006, Jämsen et al. 2006, Pietsch et 
al. 2006, Souillac et al. 2006, Trezies et al. 2006, Hsu et al. 
2007, Mittal et al. 2007) do not appear to be any better in this 
respect (Table 4).
Because of the heterogeneity of the studies and their materi-
als, we could not use meta-analytical techniques. Instead, the 
studies were reviewed descriptively, which limits the objec-
tivity of conclusions and leaves room for interpretative dis-
agreement. To  minimize  the  confounding  effect  caused  by 
0 5 10 15 20 25 30 35
Buechel et al. 2004    (n=22)  122 months
Goldman et al. 1996    (n=64)    90 months
Emerson et al. 2002 static    (n=26)    90 months
Haleem et al. 2004    (n=96)    86 months
von Foerster et al. 1991  (n=104)    76 months
Hofmann et al. 2005    (n=50)    74 months
Cuckler 2005    (n=44)    65 months
Mont et al. 2000    (n=69)    63 months
Göksan et al. 1992    (n=18)    60 months
Lonner et al. 2001    (n=53)    56 months
Haddad et al. 2000    (n=45)    48 months
Jhao and Jiang 2003      (n=7)    42 months
Gacon et al. 1997    (n=29)    42 months
Meek et al. 2004    (n=54)    41 months
Emerson et al. 2002 mobile    (n=22)    36 months
Fehring et al. 2000 static    (n=25)    36 months
Durbhakula et al. 2004    (n=24)    33 months
Rosenberg et al. 1988    (n=26)    29 months
MacAvoy et al. 2005    (n=13)    28 months
Henderson and Booth 1991    (n=28)    27 months
Fehring et al. 2000 mobile    (n=15)    27 months
Masri et al. 1994    (n=24)    26 months
Booth and Lotke 1989    (n=25)    25 months
Whiteside 1994    (n=33)    24 months
Pitto et al. 2005    (n=21)    24 months
Lu et al. 1997      (n=8)    20 months
Kirschner et al. 2000      (n=6)    19 months
Siebel et al. 2002    (n=10)    18 months
McPherson et al. 1997    (n=21)    17 months
Pietsch et al. 2003    (n=24)    15 months
Lecuire et al. 1999    (n=12)    12 months
Gusso et al. 1995      (n=5)      unknown
Hirakawa et al. 1998    (n=55)      unknown
% of cases
Recurrent infection
New infection
 
Re-infection rate Study
Figure 1. Rates of recurrent and new infections. Studies sorted by length of follow-up.
series of 55 cases with static PMMA 
spacers, with an average follow-up 
of 62 months. During the follow-
up, a decline in both clinical score 
(–6.7 points) and range of motion 
(–9 degrees) was seen.
2  studies  comparing  static  and 
mobile spacers have been published 
(Fehring  et  al.  2000,  Emerson  et 
al. 2002). Clinical scores were not 
reported  in  these  studies.  In  both 
studies,  the  static  spacer  group 
comprised  a  number  of  historical 
controls treated with static PMMA 
spacer.  There  was  no  statistically 
significant  difference  between 
shaped articulating PMMA spacers 
and static spacers regarding postop-
erative range of motion (Fehring et 
al.  2000).  In  contrast,  articulating 
spacers made of resterilized pros-
thesis components resulted in supe-
rior postoperative range of motion 
(Emerson et al. 2002). This led the 
authors to conclude that the more 
the  spacer  resembles  a  real  total 
knee prosthesis, the better the clini-
cal outcome will be. In both studies 
the use of a historical control group 
introduces a time period effect as 
a  confounding  factor,  which  may 
partly explain the difference.72  Acta Orthopaedica 2009; 80 (1): 67–77
heterogeneous materials, only papers reporting a pure series 
of either one-stage or two-stage revision for deep knee infec-
tion were included. Consequently, some potentially relevant 
papers (Rand et al. 1983, Bengtson and Knutson 1991, Hans-
sen et al. 1994) were excluded. Despite these exclusions, the 
papers included represent substantial experience in two-stage 
exchange  arthroplasty  especially,  with  over  3,000  person-
years of follow-up documented.
There was—and there still is—no question about the role 
of the two-stage approach being the gold standard in the man-
agement of infected knee replacements. Thus, our aim was 
to detect any factors that might have a relationship with the 
outcome variables under study. A trend suggesting such a rela-
tionship was found between the type of spacer and the rate of 
recurrence of infections, and also between the type of spacer 
and postoperative range of motion (or maximal flexion). How-
ever, as it appears that recurrence rate has declined over the 
containing bone cement may provide ground for microbial 
adhesion and bacterial growth (van de Belt et al. 2000, Neut et 
al. 2005); thus, spacers of any kind may encourage recurrence 
of infection (Hart and Jones 2006, Jämsen et al. 2006). One 
should be prepared to remove an already implanted spacer and 
to redebride the joint in order to achieve control over the infec-
tion when markers of inflammation do not normalize or when 
the symptoms continue after the first-stage operation. For the 
same reason, two-stage revision (even without a spacer) may 
be the best approach in complicated cases, since a higher treat-
ment failure rate has been reported in multiply-operated knees 
(Hart and Jones 2006), in the case of resistant pathogens such 
as methicillin-resistant staphylococci (Mittal et al. 2007), and 
in compromised hosts.
A deep infection is an expensive complication (Bengtson 
et al. 1989, Sculco 1993, 1995, Hebert et al. 1996, Bozic and 
Ries 2005) and the outcome of two-stage revisions is probably 
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Figure 2. Rates of recurrent and new infections after revision arthroplasty for infection. 
Series sorted by publication year.
past 2 decades (Figure 2; Goldman et al. 1996, 
Hirakawa et al. 1998, Haleem et al. 2004, Sheng 
et al. 2006), and articulating spacers have been 
introduced quite recently, it is unclear whether 
the low recurrence rate with articulating spac-
ers is due to a decline in general recurrence rate 
or the type of spacer per se. With clinical scores 
and range of motion, the case-to-case variation 
was high and definitive conclusions could not be 
drawn from the present data. The results of the 
comparative studies (Fehring et al. 2000, Emer-
son et al. 2002, Jämsen et al. 2006, Hsu et al. 
2007) may have been biased due to the use of 
historical control groups, or to differences in the 
length of follow-up.
Spacers to be used during the interim period 
between  resection  and  reimplantation  opera-
tions were introduced to maintain joint cavity 
and to prevent contractures of periarticular soft 
tissues and, to thereby facilitate the reimplanta-
tion. Mobile spacers are thought to ease patients’ 
ambulation and prevent soft tissue contractures 
and muscle atrophy. In our study, no factors that 
could be reliably related to improved postopera-
tive outcome were detected. A slight trend sug-
gesting some advantage of mobile spacers over 
other types was seen, but only concerning range 
of motion (Figure 3).
Though  advantages  of  spacers  of  any  type 
could not be proven, the results of our review 
and of the most recent reports (Hart and Jones 
2006, Huang et al. 2006, Jämsen et al. 2006, 
Hsu et al. 2007) strongly suggest that the use 
of articulating spacers—or even definitive new 
knee prostheses (Trezies et al. 2006)—does not 
affect the chances of eradicating an infection. 
However, foreign material and even antibiotic-Acta Orthopaedica 2009; 80 (1): 67–77  73
worse than that of aseptic revisions (Barrack et al. 2000a, b, 
Wang et al. 2004). For these reasons, there has been increased 
interest in easier ways of managing infected TKAs. Unfortu-
nately, pure antibiotic therapy, lavage procedures, and debride-
Figure 3. The effect of treatment approach on the average postoperative 
range of motion or maximal flexion. Each dot represents one study.
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regimen was used and the antibiotics were selected according 
to the results of bacterial culture, but few publications have 
given details of the antibiotic treatment. This can be inter-
preted as indicating confidence in the importance of surgical 
ment with retention of the prosthesis have very limited 
indications (Silva et al. 2002, Leone and Hanssen 2006). 
Thus, the question in practice is whether one-stage revi-
sion is an acceptable approach or not—or how the proto-
col of two-stage revisions could be improved.
Although reinfection rates of only 9% and 11% after 
one-stage revision have been reported (Göksan and Free-
man 1992, Buechel et al. 2004), the high failure rate of 
27% per primum intentionem reported by von Foerster 
et al. (1991) indicates that the outcome is not as predict-
able as that of staged exchange. No cost-effectiveness 
analyses have been published. Considering the probably 
catastrophic outcome of repeat revisions for septic fail-
ure, further studies are required to define the indications 
for this approach.
Of the different modifications of the conventional two-
stage approach, the recently reported protocol with shorter 
(2–3-week) antibiotic treatment has resulted in reasonable 
eradication rates (Hoad-Reddick et al. 2005, Hart and 
Jones 2006), but at present only short-term follow-up is 
available and there have been no published studies com-
paring short antibiotic treatment with extensive antibiotic 
treatment. In most of the studies reviewed, a 4–6-week 
Table 4. Overview of studies published after the literature search 
  A  B  C  D  E  F  G  H  I
   Hart and Jones  2006   48   1998–2003   articulating PMMA      49 (26–85)   88   NA     c 
   Huang et al.   2006   21   1996–2002   RPS     52 (30–102)   95   85  81 a
   Jämsen et al.   2006   34   1993–2003   RPS (n = 24)     25 (2–68)   91  104  82 a
              static PMMA (n = 10)    49 (2–86)   75   92  79 a 
   Trezies et al.   2006   11   1992–2004  new femoral component +    65   91   NA 
          polyethylene tibial insert
   Hsu et al.   2007  28   1996–2004   static PMMA (n = 7)   101 (63–120)  86   78  81 a 
              articulating PMMA (n = 21)    58 (27–96)   91   95  89 a
   Mittal et al.   2007   37   1987–2003   articulating or static PMMA      51 (24–111)   75   NA     d 
Abstracts        
   Pietsch et al.    2006   33   2000–2003  RPS     28 (12–48)   91     87 b  e   
   Souillac et al.   2006   28   2000–2003   articulating PMMA     (20–48)   86   NA 
NA: not available; PMMA: polymethylmethacrylate bone cement; RPS: resterilized prosthesis spacer
 
A  Study  
B  No. of knees 
C Year(s) of collection 
D Spacer 
E  Follow-up, months (range) 
F  Infection eradication rate, % 
G Range of motion, degrees
H Clinical outcome
  a  Knee Society score
  b  Hospital for Special Surgery knee score
I  Note
  c  short-term antibiotic therapy
  d  resistant organisms: methicillin-resistant Staphylococcus aureus/epidermidis
  e  prospective study74  Acta Orthopaedica 2009; 80 (1): 67–77
intervention as opposed to the use of postoperative antibiot-
ics, although the use of antibiotic-impregnated cement as local 
antibiotic carrier seems to be widely accepted. The optimal 
type and length of antibiotic therapy in exchange arthroplasty 
could not be gleaned from the results of this review.
One of the major problems with the comparisons between 
the different treatment approaches used in this study is the 
possibility of selection bias. It is possible that the patients 
selected  for  one-stage  revision  or  two-stage  revision  with 
mobile spacer prosthesis were healthier than those patients for 
whom two-stage revision was performed, for example, with-
out any spacers. In such cases, the comparisons may be biased 
in favor of treatment alternatives, to optimize the changes to 
eliminate the infection. Such selection by surgeon’s prefer-
ence would bias comparisons in favor of treatment alternatives 
other than the conventional two-stage exchange arthroplasty. 
Inclusion and exclusion criteria, and also the primary diagno-
ses and patient comorbidity indices were seldom reported. For 
these reasons, the confounding effects of host status and type 
of infection—and also of possible selection bias—could not 
be analyzed. 
The studies reviewed report rather similar success rates of 
82–100% in eradication of infection. The rates are comparable 
to those of the more recently published series and to those of 
series published in languages other than English (Tables 2 and 
4). The survival rates (77–80% at 10 years) (Goldman et al. 
1996, Hirakawa et al. 1998, Haleem et al. 2004) are similar 
to the published survival rates of 85–90% following revision 
arthroplasty for infection in a nationwide series in Finland 
(Sheng et al. 2006). Thus, it seems that the reports from spe-
cialized hospitals do not give over-optimistic results but that 
similar results can be obtained in different institutions.
The factors that affect the outcome of exchange arthroplasty 
remain largely unknown. Clinical experience and studies on 
infected  hip  and  knee  arthroplasty  suggest  that  host  status 
(comorbidity), type of infection (acute vs. chronic), and the 
condition of the environment of the joint involved contribute 
to the outcome of infected knee replacement (McPherson et 
al. 1999, 2002). These or any other factors that contribute to 
the outcome were not adequately analyzed in any of the stud-
ies reviewed. Because of the lack of detailed data on treat-
ment failures, such analyses could not be performed using the 
results of this systematic review either. Future research should 
focus on the factors affecting the outcome of different treat-
ment approaches.
Conclusions
Most reports on exchange arthroplasty performed for infected 
knee arthroplasty are of poor methodological quality, and no 
unbiased comparative studies exist. The previously reported 
series included in this systematic analysis yielded similar suc-
cess rates, but the factors that could predict the outcome are 
mostly unknown. In the light of our findings, two-stage revi-
sion with delayed reimplantation remains the gold standard. It 
seems reasonable to employ mobile spacers where possible, as 
they do not compromise the attempts to eradicate infection but 
may improve postoperative outcome. Despite some promis-
ing preliminary reports, the value of and indications for direct 
exchange arthroplasty remain unclear. Future studies focus-
ing on these treatments should preferably use a prospective 
randomized setting and compare the new approach to the gold 
standard of two-stage exchange arthroplasty.
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Appendix 1. Data sources and strategy of the literature review
Literature databases reviewed:
Medline 1966 to present (via Ovid), Medline Daily Update (via Ovid), Medline In-Process and Other Non-indexed 
Citations (via Ovid), CINAHL (via Ovid), British Nursing Index (via Ovid), Cochrane Central Register of Controlled 
Trials (via Ovid), Cochrane Database of Systematic Reviews (via Ovid), Database of Abstracts of Reviews of Effects 
(via Ovid), ACP Journal Club (via Ovid), NHS Health Technology Assessment (via CRD), NHS Economic Evaluation 
Database (via CRD). 
Search strategy for Medline and CINAHL:
  1)  arthroplasty, replacement, knee/
  2)  knee prosthesis/
  3)  “knee prosthes$”.mp
  4)  “knee arthroplast$”.mp
  5)  “knee replacement?”.mp
  6)  reoperation/
  7)  “revis$”.mp
  8)  “reimplant$”.mp
  9)  “exchang$”.mp
10)   prosthesis-related infections/
11)   infection/
12)   wound infection/
13)   surgical wound infection/
14)   “infect$”.mp
15)   (1 or 2 or 3 or 4 or 5) and (6 or 7 or 8 or 9) and (10 or 11 or 12 or 13 or 14)
Search strategy for EBM databases: Cochrane Central Register of Controlled Trials, Database or Abstracts of Reviews 
of Effects, Cochrane Database of Systematic Reviews, ACP Journal Club (via Ovid):
  1)  knee replacement?.mp
  2)  knee arthroplast$.mp
  3)  knee prosthes$.mp
  4)  arthroplasty, replacement, knee.mp
  5)  reoperat$.mp
  6)  revis$.mp
  7)  reimplant$.mp
  8)  exchang$.mp
  9)  infect$.mp
10)  prosthesis-related infection?.mp
11)  (1 or 2 or 3 or 4) and (5 or 6 or 7 or 8) and (9 or 10)
Search strategy for Science Citation Index:
  1)  TS=arthroplasty
  2)  TS=infection
  3)  TS=knee
  4)  TS=(revision OR reoperation OR reimplantation OR exchange)
  5)  #1 AND #2 AND #3 AND #4
Search strategy for Health Technology Assessment, NHS Economic Evaluation Database:
  1)  prosthesis-related infections (subject headings)
  2)  arthroplasty-replacement-knee (subject headings) OR knee-prosthesis (subject headings) AND infect (all fields)
  3)  knee replacem OR knee arthroplas AND infectActa Orthopaedica 2009; 80 (1): 67–77  77
Appendix 2. The form used for assessment of study quality
STUDY QUALITY  Question:  Yes; No; Unclear
Was the patient population described in sufficient detail so that you could compare it to the patient population you treat or to the 
materials of other studies on the same subject?   
–  Average age   
–  Male-to-female ratio   
–  Indications for primary knee replacement   
–  ASA classification   
–  Pathogens identified   
–  Preoperative Knee Society (KSS) or Hospital for Special Surgery (HSS) knee score   
–  Preoperative range of motion   
Was the intervention described in sufficient detail so that you could provide the same treatment for your own patiens?    
–  Use of antibiotics peroperatively   
–  The type of spacer used in two-stage revisions   
–  The length of interim period between the stages in two-stage revisions   
Was the associated treatment/rehabilitation described in sufficient detail so that you could provide the same for your own patients?   
–  Use of antibiotics postoperatively   
–  Rehabilitation   
Were the primary outcome variables reported?   
–  Number of all post-treatment infections   
–  Number of reinfections    
–  Postoperative KSS or HSS   
–  Postoperative range of motion   
Were both advantages and disadvantages of the treatment presented? 
Was the proportion of patients excluded less than 20% of the number of patients included?   
Was the species of infecting pathogen used as exclusion criterion?   
Was loss to follow-up less than 20%?     